Glatiramer Acetate (GA) in Patients With a First Episode of Acute Optic Neuritis
- Study Title
- A Randomized, Double-blind, Placebo-controlled, Multicenter Study of the Effects of Glatiramer Acetate (GA) on the Retinal Nerve Fiber Layer (RNFL) and Visual Function in Patients With a First Episode of Acute Optic Neuritis (AON). (Octagon)
- Teva Identifier
- PM030
- ClinicalTrials.gov Identifier
- NCT00856635
- Study Status
- Completed
- Trial Condition(s)
- Optic Neuritis
- Interventions
- Drug: Glatiramer Acetate | Drug: placebo
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult
- Age Range
- 18 Years to 45 Years
- Trial Duration
- 02/01/2009 - 02/01/2011
- Phase
- Phase 3
